当前位置：首页 > 文献互助 > 互助详情

O11-1 LITESPARK-005 East Asian subgroup: belzutifan versus everolimus for previously treated advanced renal cell carcinoma复制

用户4Ud7YDZAY51U 1小时前 13 10 待确认 帖子自动结束时间: 2026-01-21 14:17:32

1. 请及时下载文件确认是否正确, 系统将在 2026-01-23 14:53:33 删除文件

2. 如若文件有误请驳回应助文件, 求助状态即回到求助中

3. 如若文件正确请及时点击确认, 若超过时后系统自动默认为已完结

注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规

DOI:复制

文献链接:复制

其他信息:

S Park
Annals of Oncology, 2025
annalsofoncology.org
… Background: In the randomized phase 3 LITESPARK-005 … minimum follow-up of East Asian
pts from LITESPARK-005. … follow-up of East Asian pts from LITESPARK005, PFS and ORR …

上一篇：Nerandomilast (BI 1015550): an efficient PDE4 inhibitor for the potential treatment of idiopathic pulmonary fibrosis

下一篇：A phosphate starvation response-centered network regulates mycorrhizal symbiosis

互助时间线

2026-01-16 14:53:33 [上传文件]

jodie0105上传了文件(pdf 189.88 KB), 求助状态变成 待确认

2026-01-16 14:17:32 [发起求助]

最新发布的求助

Bi-directional communication between intrinsic enteric neurons and ILC2s inhibits host defense against helminth infection 4分钟前
Digital Pathology and Artificial Intelligence Applied to Nonclinical Toxicology Pathology—The Current State, Challenges, and Future Directions 7分钟前
Digital pathology and artificial intelligence in diagnostic pathology 10分钟前
Midkine-Mediated Microglia Activation after Renal Injury Promotes Cognitive Impairment Following Ischemic Renal Injury 22分钟前
Generative Artificial Intelligence in Anatomic Pathology 23分钟前
MATHEMATICAL MODELING AND NUMERICAL ANALYSES OF TRANSPORT PHENOMENA WITH VARIABLE CROSS-DIFFUSION AND NONLINEAR RADIATION 24分钟前
Blood—Brain Barrier 33分钟前
Molecular catalyst converts carbon dioxide to methanol 43分钟前
Divergence and plasticity shape adaptive potential of the Pacific oyster 47分钟前
Dihydroartemisinin alleviates mitochondrial damage and improves cardiomyocyte pyroptosis and ferroptosis through Sirt1-mediated PGC-1α 54分钟前
Phosphoproteomics reveals therapeutic targets of esophageal squamous cell carcinoma 57分钟前
An overview of KRAS G12D inhibitors: Expanding the therapeutic frontier of KRAS in targeting KRAS G12D using diverse therapeutic modalities 59分钟前

wispass工作室 Copyright © 蜀ICP备2024051606号-2 www.wispass.com